Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
about
Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality.Synthetic polymer nanoparticle-polysaccharide interactions: a systematic study.Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registryClinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.Safety of Routine Invasive Versus Selective Invasive Therapy in Women with Non-ST-Elevation Acute Coronary Syndrome.Safety evaluation of enoxaparin in currently approved indications.Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS).Enoxaparin: a pharmacologic and clinical review.Emerging therapies for acute coronary syndromesPromise of factor Xa inhibition in acute coronary syndromes.Unstable angina and non-ST elevation myocardial infarction.Cost effectiveness of anticoagulation in acute coronary syndromes.Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis.Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection.Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of EConsensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pInfluence of clinical trial participation on subsequent antithrombin use.A comparison of the biological activity of 2 formulations of enoxaparin in 12 healthy volunteers.Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.Heparin or enoxaparin anticoagulation for primary percutaneous coronary interventionAn unusual case of massive subcutaneous chest wall haemorrhage with enoxaparinPre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of CardiologyThe Efficacy and Safety of Enoxaparin: A Meta-analysis
P2860
Q30235552-FBDDC5C2-3AC0-4A11-AF8C-1CAD34395581Q31044576-DA6EFC68-058A-42BC-8565-E8AE0FBE7EE0Q34196711-38136926-E9B5-4DF6-B6EC-0828C056F7E4Q34255603-DC9F8938-B76C-43B9-A527-D516EAC52E94Q34415964-931D07EC-489E-463C-9BBD-99D5B87AB306Q36999940-40427C0A-782B-4F0A-9F32-EEF9A79B7EAEQ37622250-4A03513C-2924-48F2-A707-0B3F523E52DCQ37788728-8EC0355C-A05D-4D54-957A-02AFC080CEA9Q37862264-4382220D-527F-4D86-AD96-8757EC825B7CQ37949587-37551A45-EBE2-41EE-9EB2-3A02E16DA716Q37955861-5BCF093E-8992-4E7B-8054-29E6489E0FDEQ37972109-FD9AFC3E-74B1-4563-B32D-D890A09D3363Q37992680-9BE5D396-8767-484F-9AB6-E2715B8B3E0CQ38106501-F7655023-AFDF-4763-B4E8-7BC3FA05B3F8Q38108138-48EC10C5-73FC-4DE2-AE91-CDDFEC7981CDQ38199360-14089C15-345F-4CE6-AA69-37E106333034Q38656364-9F4E9E89-401D-4091-91CD-891FDB4556B7Q41082977-B72F0334-489F-4BE0-AC14-B025C76FE7A4Q43175938-DEA5B67B-7216-4B61-9BC8-79D6634E01DFQ43293900-70A8F51F-A746-4EC3-9522-70DAF46771ACQ46083556-41F420C2-AB57-4456-9A4D-90D85E034958Q56837771-B674D26D-8EED-4A1B-8BEE-E87092A72D19Q58166537-3E127935-DD05-40F1-BEA2-C7600BA1D09FQ58292876-FBB4073A-B7A9-4A1E-ADE0-091567FD5767Q58757769-BCA9BAFF-1D4F-4922-BA26-E20023B68B64
P2860
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Efficacy and safety of the low ...... ome spectrum: a meta-analysis.
@en
type
label
Efficacy and safety of the low ...... ome spectrum: a meta-analysis.
@en
prefLabel
Efficacy and safety of the low ...... ome spectrum: a meta-analysis.
@en
P2093
P50
P356
P1476
Efficacy and safety of the low ...... ome spectrum: a meta-analysis.
@en
P2093
Carolyn H McCabe
Charles Michael Gibson
David A Morrow
Ian B Menown
Marc Cohen
Sabina A Murphy
Shaun G Goodman
P304
P356
10.1093/EURHEARTJ/EHM224
P577
2007-06-28T00:00:00Z